We are live on
!
Find out more
CCP
Clough Capital Partners Portfolio holdings
AUM
$1.04B
1-Year Est. Return
49.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.97%
1 Year Est. Return
+49.7%
3 Year Est. Return
+155.82%
5 Year Est. Return
+205.73%
10 Year Est. Return
+1,385%
AUM
$977M
AUM Growth
+$61.2M
(+6.7%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
1.6%
Top 10 Holdings %
Top 10 Hldgs %
35.78%
Holding
149
New
31
Increased
28
Reduced
46
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$17.7M |
| 2 |
Dell
DELL
|
+$17.1M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$15.1M |
| 4 |
PLGO
Pelagos Insurance Capital
PLGO
|
+$11.1M |
| 5 |
Cigna
CI
|
+$9.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$16M |
| 2 |
Eli Lilly
LLY
|
+$15.2M |
| 3 |
Microsoft
MSFT
|
+$14M |
| 4 |
UnitedHealth
UNH
|
+$11.2M |
| 5 |
Apple
AAPL
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 22.48% |
| 2 | Technology | 20.72% |
| 3 | Healthcare | 12.89% |
| 4 | Industrials | 12% |
| 5 | Communication Services | 9.71% |
Similar funds
CGA
SM
RC
OPFM
MSIIA
CA
TBA
CFFNO
Clough Capital Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Clough Capital Partners held 149 positions worth $977M, up 6.7% from $916M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Clough Capital Partners's Q3 2024 filing shows 31 new, 28 increased, 46 reduced and 17 closed positions. Its largest new stake was Bristol-Myers Squibb: 376,952 shares worth $19.5M. The largest sale was Merck, an estimated $16M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Clough Capital Partners's largest Q3 2024 buy was Bristol-Myers Squibb: 376,952 shares worth $19.5M.
- Clough Capital Partners added most to Dell in Q3 2024, an estimated $17.1M increase.
- Clough Capital Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $15.2M.
- Clough Capital Partners fully exited Merck in Q3 2024, selling an estimated $16M.
- Clough Capital Partners's ten largest holdings make up 36% of its $977M portfolio in Q3 2024.
- Clough Capital Partners opened 31 new positions and closed 17 in Q3 2024.
- Clough Capital Partners's portfolio value rose 6.7% quarter-over-quarter to $977M.
Based on Clough Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.